We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Relx Plc | LSE:REL | London | Ordinary Share | GB00B2B0DG97 | ORD 14 51/116P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 48.00 | 1.46% | 3,329.00 | 3,327.00 | 3,328.00 | 3,331.00 | 3,291.00 | 3,303.00 | 2,293,088 | 16:35:21 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Miscellaneous Publishing | 9.16B | 1.78B | 0.9458 | 35.18 | 62.65B |
From Apr 2019 to Apr 2024
By Rory Gallivan
LONDON--RELX PLC (REL.LN), the professional information company formerly known as Reed Elsevier, today reported underlying revenue growth of 4% in the first nine months of calendar year 2016 and kept its full-year outlook unchanged.
The publisher of titles such as medical journal The Lancet and organizer of exhibitions including the London Book Fair, reported underlying revenue growth in all its divisions.
Write to Rory Gallivan at rory.gallivan@wsj.com; Twitter: @RoryGallivan
(END) Dow Jones Newswires
October 27, 2016 02:26 ET (06:26 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
1 Year Relx Chart |
1 Month Relx Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
